These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 32185172)

  • 21. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
    Zhang J; Liu L; Li J; Le TD
    Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma.
    Huang M; Zhong Z; Lv M; Shu J; Tian Q; Chen J
    Oncotarget; 2016 Jul; 7(30):47186-47200. PubMed ID: 27363013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development and controversy of competitive endogenous RNA hypothesis in non-coding genes.
    Lin W; Liu H; Tang Y; Wei Y; Wei W; Zhang L; Chen J
    Mol Cell Biochem; 2021 Jan; 476(1):109-123. PubMed ID: 32975695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
    Wang H; Niu L; Jiang S; Zhai J; Wang P; Kong F; Jin X
    Oncotarget; 2016 Dec; 7(52):86174-86185. PubMed ID: 27863388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.
    Gao H; Chen X; Shang Z; Niu Y
    Oncol Rep; 2018 Aug; 40(2):959-967. PubMed ID: 29901101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer.
    Li M; Liu Y; Zhang X; Liu J; Wang P
    Gene; 2018 Nov; 677():189-197. PubMed ID: 30025927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant Expression of Pseudogene-Derived lncRNAs as an Alternative Mechanism of Cancer Gene Regulation in Lung Adenocarcinoma.
    Stewart GL; Enfield KSS; Sage AP; Martinez VD; Minatel BC; Pewarchuk ME; Marshall EA; Lam WL
    Front Genet; 2019; 10():138. PubMed ID: 30894871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of competing endogenous RNAs in gastric cancer.
    Hu Y; Tian H; Xu J; Fang JY
    Brief Funct Genomics; 2016 May; 15(3):266-73. PubMed ID: 26404556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and analysis of a dysregulated lncRNA-associated ceRNA network in a rat model of temporal lobe epilepsy.
    Luo ZH; Walid A A; Xie Y; Long H; Xiao W; Xu L; Fu Y; Feng L; Xiao B
    Seizure; 2019 Jul; 69():105-114. PubMed ID: 31005697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
    Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
    Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
    Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
    Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
    Luo Q; Cui M; Deng Q; Liu J
    Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent progress of exosomal lncRNA/circRNA-miRNA-mRNA axis in lung cancer: implication for clinical application.
    Wang R; Xu Y; Tong L; Zhang X; Zhang S
    Front Mol Biosci; 2024; 11():1417306. PubMed ID: 39021878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of circular RNA-associated competing endogenous RNA network in the development of cleft palate.
    Shu X; Cheng L; Dong Z; Shu S
    J Cell Biochem; 2019 Sep; 120(9):16062-16074. PubMed ID: 31074068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
    Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY
    Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential prognostic ceRNA module biomarkers in patients with pancreatic adenocarcinoma.
    Zhao L; Liu B
    Oncotarget; 2017 Nov; 8(55):94493-94504. PubMed ID: 29212244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.